Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy

References

• TangCYZhuLXYuJDEffect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanismEur J Pharm Sci2018120202929704644
   PubMed Web of Science ®Google Scholar
• JiangZJacobJALoganathachettiDSNainanguPChenBβ-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization EffectFront Pharmacol20170827105
   Google Scholar
• YuXXuMLiNβ-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancerBiochem Biophys Res Commun2017490251452028624450
   PubMed Web of Science ®Google Scholar
• GuoZLiuZYueHWangJBeta-elemene increases chemosensitivity to 5-fluorouracil through down-regulating microRNA-191 expression in colorectal carcinoma cellsJ Cell Biochem201811987032703929737579
   PubMed Web of Science ®Google Scholar
• ZhuTZLiXMLuoLHβ-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cellsInt J Oncol201445269970924841897
   PubMed Web of Science ®Google Scholar
• ZhuTZLiXMLuoLHβ-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal-regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cellsMol Med Rep20141021122112824866280
   PubMed Web of Science ®Google Scholar
• LiQQLeeRXLiangHZhongYReedEEnhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cellsMed Oncol201330142423277286
   PubMed Web of Science ®Google Scholar
• QqLWangGHuangFJmLCuffCFReedESensitization of lung cancer cells to cisplatin by beta-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of beta-elemene and its synthetic analogsMed Oncol201330148823397083
   PubMed Web of Science ®Google Scholar
• QqLWangGLiangHβ-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomasAnticancer Res2013334142123564782
   PubMed Web of Science ®Google Scholar
• MuLWangTChenYTangXYuanYZhaoYβ-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathwayInt J Oncol20164941427143627498706
   PubMed Web of Science ®Google Scholar
• ZhangFXuLQuXSynergistic antitumor effect of beta-elemene and etoposide is mediated via induction of cell apoptosis and cell cycle arrest in non-small cell lung carcinoma cellsMol Med Rep2011461189119321904777
   PubMed Web of Science ®Google Scholar
• JiangZYQinSKYinXJChenYLZhuLSynergistic effects of Endostar combined with β-elemene on malignant ascites in a mouse modelExp Ther Med20124227728423139716
   PubMed Web of Science ®Google Scholar
• ZhouJHeLLDingXFCombinatorial Antitumor Effect of Rapamycin and β-Elemene in Follicular Thyroid Cancer CellsBiomed Res Int201620165672380727274989
   PubMedGoogle Scholar
• LiXLinZZhangBβ-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1Sci Rep2016612101026867799
   PubMedGoogle Scholar
• ZouBLiQQZhaoJLiJMCuffCFReedEβ-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cellsAnticancer Res201333392994023482764
   PubMed Web of Science ®Google Scholar
• LiGXieBLiXDownregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograftsOncol Rep20153331427143325607351
   PubMed Web of Science ®Google Scholar
• LiuSZhouLZhaoYYuanYβ-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathwayOncol Rep201534294395126062577
   PubMed Web of Science ®Google Scholar
• WuZWangTZhangYAnticancer effects of β-elemene with hyperthermia in lung cancer cellsExp Ther Med20171363153315728588670
   PubMed Web of Science ®Google Scholar
• ZhangGNAshbyCRJrZhangYKChenZSGuoHThe reversal of antineoplastic drug resistance in cancer cells by β-elemeneChin J Cancer2015341148849526370907
   PubMedGoogle Scholar
• FangMMeiXYaoHβ-elemene enhances anticancer and anti-metastatic effects of osteosarcoma of ligustrazine in vitro and in vivoOncol Lett20181533957396429467906
   PubMed Web of Science ®Google Scholar
• LeeRXLiQQReedEβ-Elemene Effectively Suppresses the Growth and Survival of Both Platinum-sensitive and -resistant Ovarian Tumor CellsAnticancer Res20123283103311322843880
   PubMed Web of Science ®Google Scholar
• LiCLChangLGuoLβ-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2Asian Pac J Cancer Prev20141523104071041225556484
   PubMedGoogle Scholar
• LiJJunYuLiuAWangYβ-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosomeLung Cancer201486214415025204604
   PubMed Web of Science ®Google Scholar
• LiuYJiangZYZhouYLβ-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathwayBiomed Pharmacother20179349049728672279
   PubMed Web of Science ®Google Scholar
• WangLZhaoYWuQGuanYWuXTherapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cellsMol Med Rep20181734299430629363722
   PubMed Web of Science ®Google Scholar
• ZhuTLiXLuoLReversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related moleculesJ Transl Med201513135626563263
   PubMedGoogle Scholar
• FengHBWangJJiangHRβ-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1Stem Cells Transl Med20176383083928297578
   PubMed Web of Science ®Google Scholar
• TongEXuYLiGZouKZouLThe effects of β-elemene on the expression of mTOR, HIF-1α, surviving in lung adenocarcinoma A549 cellAfr J Tradit Complement Altern Med2013104182324146496
   PubMedGoogle Scholar
• ZhaoSWuJZhengFβ-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1J Cell Mol Med201519363064125598321
   PubMed Web of Science ®Google Scholar
• HuangCYuYSynergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling PathwayMed Sci Monit2017231507151328355175
   PubMed Web of Science ®Google Scholar
• ShiHLiuLLiuLGengJZhouYChenLβ-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9Melanoma Res20142429910724535052
   PubMed Web of Science ®Google Scholar
• HuZWuHLiYβ-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expressionAnticancer Drugs201526553153925646744
   PubMed Web of Science ®Google Scholar
• ZhangJZhangHChenLβ-elemene reverses chemoresistance of breast cancer via regulating MDR-related microRNA expressionCell Physiol Biochem20143462027203725562151
   PubMedGoogle Scholar
• ZhangJZhangHDYaoYFZhongSLZhaoJHTangJHβ-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via ExosomesCell Physiol Biochem20153662274228626279432
   PubMedGoogle Scholar
• ChenMWangSTanMWangYApplications of nanoparticles in herbal medicine: zedoary turmeric oil and its active compound β-elemeneAm J Chin Med20113961093110222083983
   PubMed Web of Science ®Google Scholar
• ChangZGaoMZhangWSongLJiaYQinYBeta-elemene treatment is associated with improved outcomes of patients with esophageal squamous cell carcinomaSurg Oncol201726433333729113648
   PubMed Web of Science ®Google Scholar
• MaCZhouWYanZQuMBuXβ-Elemene treatment of glioblastoma: a single-center retrospective studyOnco Targets Ther201697521752628003765
   PubMed Web of Science ®Google Scholar
• ZhengCCaiXWuSLiuZShiYZhouWEnhancing effect of beta-elemene emulsion on chemotherapy with harringtonine, aclacinomycin, and Ara-c in treatment of refractory/relapsed acute myeloid leukemiaPak J Med Sci20143061270127225674121
   PubMed Web of Science ®Google Scholar
• LyXHiDZhangMHDongJHThe advances in anti-tumor activity and relationship between structure and activity of β-elemene derivativesProceedings of the 13th Chinese Pharmacist WeekNanning, Guangxi, China2 November 2013BeijingChinese Pharmaceutical Association2013
   Google Scholar
• HuynhDLSharmaNKumar SinghAAnti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathwaysChin J Nat Med2017151154028259249
   PubMed Web of Science ®Google Scholar
• WangKLiZChenYSuCThe pharmacokinetics of a novel anti-tumor agent, beta-elemene, in Sprague-Dawley ratsBiopharm Drug Dispos200526730130716041842
   PubMed Web of Science ®Google Scholar
• ZhangMZhangLYDongXZLiuPSpectroscopic studies on binding of beta-elemene to human serum albuminZhongguo Zhong Yao Za Zhi201439112117212025272854
   PubMedGoogle Scholar
• ChenZSongYCheJValidation of a sensitive gas chromatographic-mass spectrometric method for the simultaneous determination of beta-elemene and beta-elemenal in human plasmaJ Chromatogr B Analyt Technol Biomed Life Sci20098774408414
   PubMed Web of Science ®Google Scholar
• WangYDengYMaoSJinSWangJBiDCharacterization and body distribution of beta-elemene solid lipid nanoparticles (SLN)Drug Dev Ind Pharm200531876977816221611
   PubMed Web of Science ®Google Scholar
• WangYZStudy on β-elemene Solid Lipid Nanoparticles [doctoral thesis]ShenyangShenyang Pharmaceutical University2005
   Google Scholar
• ShiFYangGRenJGuoTDuYFengNFormulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriersInt J Nanomedicine201382533254123901271
   PubMed Web of Science ®Google Scholar
• WangXMStudies on β-elemene Liposome [doctoral thesis]ShenyangShenyang Pharmaceutical University2005
   Google Scholar
• ZengZZhouGWangXPreparation, characterization and relative bioavailability of oral elemene o/w microemulsionInt J Nanomedicine2010556757220856831
   PubMed Web of Science ®Google Scholar
• ZMLiThe Preparation Research of Solid SMEDDS for β-elemeneShandongShandong University of Traditional Chinese Medicine2009
   Google Scholar
• CJHuStudy on β-elemene Loaded Active Targeting Microemulsion Drug Delivery System Mediated by Folate Receptor [doctoral thesis]ShenyangShenyang Pharmaceutical University2011
   Google Scholar
• ChenMZhangJYuSAnti-Lung-Cancer Activity and Liposome-Based Delivery Systems of β-ElemeneEvid Based Complement Alternat Med20122012425952323243436
   PubMedGoogle Scholar
• XieTClLWangSLZengZWWangFZhaoRAdvances in the research of Elemene Liposome series targeted anticancer natural drugsChin J Integr Trad West Med20143404507512
   Google Scholar
• TapeinosCBattagliniMCiofaniGAdvances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseasesJ Control Release201726430633228844756
   PubMed Web of Science ®Google Scholar
• GarcêsAAmaralMHSousa LoboJMSilvaACFormulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A reviewEur J Pharm Sci201811215916729183800
   PubMed Web of Science ®Google Scholar
• Oude BlenkeEMastrobattistaESchiffelersRMStrategies for triggered drug release from tumor targeted liposomesExpert Opin Drug Deliv201310101399141023796390
   PubMed Web of Science ®Google Scholar
• JWQiStudy on Sterically Stabilized Liposomes of β-elemeneZhejiangZhejiang University2009
   Google Scholar
• WCLiResearch on Preparation and Pharmacokinetics for Long-Circulating β-elemene LiposomesWuhanWuhan University of Technology2010
   Google Scholar
• BelfioreLSaundersDNRansonMThurechtKJStormGVineKLTowards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunitiesJ Control Release201827711329501721
   PubMed Web of Science ®Google Scholar
• HuCMZhangLNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol20128381104111122285912
   PubMed Web of Science ®Google Scholar
• ZhangRXWongHLXueHYEohJYWuXYNanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectivesJ Control Release201624048950327287891
   PubMed Web of Science ®Google Scholar
• MengJGuoFXuHLiangWWangCYangXDCombination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivoSci Rep2016612239026947928
   PubMedGoogle Scholar
• DongBYPreparation of Compound Liposome of β-elemene and Curcumin and Study the Anti-Lung Cancer Effect Combined with DocetaxelBeijingBeijing University of Chinese Medicine2017
   Google Scholar
• CallenderSPMathewsJAKobernykKWettigSDMicroemulsion utility in pharmaceuticals: Implications for multi-drug deliveryInt J Pharm20175261–242544228495500
   PubMed Web of Science ®Google Scholar
• Xavier-JuniorFHVauthierCMoraisARVAlencarENEgitoESTMicroemulsion systems containing bioactive natural oils: an overview on the state of the artDrug Dev Ind Pharm201743570071427622950
   PubMed Web of Science ®Google Scholar
• HuCJZhaoXLLiJZPreparation and characterization of β-elemene-loaded microemulsionDrug Dev Ind Pharm201137776577421244276
   PubMed Web of Science ®Google Scholar
• AboulfotouhKAllamAAEl-BadryMEl-SayedAMRole of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variabilityColloids Surf B Biointerfaces2018167829229627681
   PubMed Web of Science ®Google Scholar
• ChenCThe Study on SEDDS Soft Capsules of β-ElemeneShenyangShenyang Pharmaceutical University2006
   Google Scholar
• Miller-KleinhenzJMBozemanENYangLTargeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesWiley Interdiscip Rev Nanomed Nanobiotechnol20157679781625966677
   PubMed Web of Science ®Google Scholar
• PerilloEPortoSFalangaALiposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell linesOncotarget2016744077409226554306
   PubMedGoogle Scholar
• WeiXGaoJZhanCLiposome-based glioma targeted drug delivery enabled by stable peptide ligandsJ Control Release2015218132126428462
   PubMed Web of Science ®Google Scholar
• Miller-KleinhenzJGuoXQianWDual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancerBiomaterials2018152476229107218
   PubMed Web of Science ®Google Scholar
• BatistGSawyerMGabrailNA multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)Clin Oncol20082615_suppl4108
   Web of Science ®Google Scholar
• BatistGGelmonKAChiKNSafety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumorsClin Cancer Res200915269270019147776
   PubMed Web of Science ®Google Scholar
• LimWSTardiPGDos SantosNLeukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine: daunorubicin formulation, in bone marrow xenograftsLeuk Res20103491214122320138667
   PubMed Web of Science ®Google Scholar
• FeldmanEJLancetJEKolitzJEFirst-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaJ Clin Oncol201129897998521282541
   PubMed Web of Science ®Google Scholar
• BrunettiCAnelliLZagariaASpecchiaGAlbanoFCPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?Expert Rev Hematol2017101085386228814164
   PubMed Web of Science ®Google Scholar
• ZhouZKennellCJafariMSequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticleInt J Pharm20175301–230030728778627
   PubMedGoogle Scholar
• SongXRCaiZZhengYReversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticlesEur J Pharm Sci2009373–430030519491019
   PubMed Web of Science ®Google Scholar
• PrasadPShuhendlerACaiPRauthAMWuXYDoxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenograftsCancer Lett2013334226327322902994
   PubMed Web of Science ®Google Scholar
• YangWHuQXuYLiuHZhongLAntibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancerMater Sci Eng C Mater Biol Appl20188932833529752104
   PubMed Web of Science ®Google Scholar
• ZhangYMuXDLiEZThe role of E3 ubiquitin ligase Cbl proteins in β-elemene reversing multi-drug resistance of human gastric adenocarcinoma cellsInt J Mol Sci2013145100751008923665906
   PubMed Web of Science ®Google Scholar
• GuoHQZhangGNWangYJβ-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporterOncol Rep201431285886624284783
   PubMed Web of Science ®Google Scholar
• WangBPengXXSunRSystematic review of β-Elemene injection as adjunctive treatment for lung cancerChin J Integr Med2012181181382323086485
   PubMed Web of Science ®Google Scholar
• MaJChenJZhaoBJJiangZYFengLJiaXBAdvance in research on anticancer drug β-elemene and its derivativesChin Tradit and Herbal Drugs201849511841191
   Google Scholar
• TaoXMGaoWBThe adverse reactions and prevention of elemene emulsion injectionADRJ20036390392
   Google Scholar
• WangYJZhangRWangWAdverse reactions caused by intravenous infusion of elemene injection in 6 casesChin Hosp Pharm J2016364337338
   Google Scholar
• XuTZhongLJsDAdverse Drug Reaction Induced by Elemene Injection: Literature Analysis of 37 CasesAsia-Pac Tradit Med2014109126128
   Google Scholar
• LiangDYangMGuoBYangLCaoJZhangXHIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosisJ Cancer Res Clin Oncol2012138111865187722736026
   PubMed Web of Science ®Google Scholar
• ZhanYHLiuJQuXJβ-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/mTOR signalling pathwaysAsian Pac J Cancer Prev20121362739274422938451
   PubMedGoogle Scholar
• LiuJHuXJJinBQuXJHouKZLiuYPβ-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cellsJ Pharm Pharmacol201264114615322150682
   PubMed Web of Science ®Google Scholar
• LiuJZhangYQuJβ-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosisBMC Cancer201111118321595977
   PubMedGoogle Scholar
• ChenJWangTXuSDiscovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathwayEur J Med Chem201713541442328463784
   PubMed Web of Science ®Google Scholar
• DingXFShenMXuLYDongJHChenG13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cellsOncol Lett2013551554155823761818
   PubMed Web of Science ®Google Scholar
• ChenJWangTXuSNovel hybrids of natural β-elemene bearing isopropanolamine moieties: Synthesis, enhanced anticancer profile, and improved aqueous solubilityFitoterapia201712011712528576721
   PubMed Web of Science ®Google Scholar
• YuZWangRXuLXieSDongJJingYβ-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROSPLoS One201161e1584321283566
   PubMed Web of Science ®Google Scholar
• XuLTaoSWangXThe synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activityBioorg Med Chem200614155351535616617020
   PubMed Web of Science ®Google Scholar
• YuZWangRXuLDongJJingYN-(beta-Elemene-13-yl)tryptophan methyl ester induces apoptosis in human leukemia cells and synergizes with arsenic trioxide through a hydrogen peroxide dependent pathwayCancer Lett2008269116517318538921
   PubMed Web of Science ®Google Scholar
• YuZWuFChenLETME, a novel β-elemene derivative, synergizes with arsenic trioxide in inducing apoptosis and cell cycle arrest in hepatocarcinoma cells via a p53-dependent pathwayActa Pharm Sin B20144642442926579413
   PubMed Web of Science ®Google Scholar
• SunYRenYZhuHRadioactive synthesis and biodistribution study of beta-elemene-99mTc(CO)3 conjugatesJ Biol Inorg Chem200914689990419360441
   PubMed Web of Science ®Google Scholar
• SunYLiuGZhangYZhuHRenYShenYMSynthesis and in vitro anti-proliferative activity of beta-elemene monosubstituted derivatives in HeLa cells mediated through arrest of cell cycle at the G1 phaseBioorg Med Chem20091731118112419128976
   PubMed Web of Science ®Google Scholar
• LiQQLeeRXLiangHZhongYAnticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cellsAnticancer Res2013331657623267129
   PubMed Web of Science ®Google Scholar